The largest database of trusted experimental protocols

4 protocols using pdgf cc

1

In vitro RPE cell culture protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human ARPE-19 cell line and primary RPE cells were from ATCC (Manassas, VA) and Lonza (Walkersville, MD), respectively. Dulbecco’s Modified Eagle’s medium (DMEM), Ham’s/F12 medium, HEPES buffer, phosphate-buffered saline (PBS), penicillin-streptomycin, fetal bovine serum (FBS), 0.05% trypsin/EDTA, recombinant human CTGF, and Alexa Fluor-conjugated secondary IgG were from Invitrogen (Carlsbad, CA, USA). Recombinant human EGF, FGF-2, HGF, IGF-1, IL-6, PDGF-AA, PDGF-AB, PDGF-BB, PDGF-CC, PTX3, and VEGF were from R & D Systems (Minneapolis, MN). Recombinant human G-CSF, IFN-γ, MCP-1, TGF-α, TGF-β1, TGF-β2, and TGF-β3 were from PeproTech (Rocky Hill, NJ). Hyaluronidase, protease inhibitors, bovine serum albumin (BSA), paraformaldehyde, methanol, Triton X-100, and Hoechst 33342 dye were from Sigma (St Louis, MO). α-SMA and BrdU antibodies were from Abcam (La Jolla, CA); β-catenin antibody was from BD Biosciences (San Jose, CA); Antibodies to lymphoid enhancer factor 1 (LEF1) and phospho-Smad2/3 were from Cell Signaling Technology (Danvers, MA). HMW HA, Healon® (~4,000 kDa, medical grade), was from Advanced Medical Optics (Santa Ana, CA). BCA Protein Assay Kit was from Pierce (Rockford, IL). HA quantitation kit was from Corgenix (Broomfield, CO). Plastic culture dishes were from Becton Dickinson (Lincoln Park, NJ).
+ Open protocol
+ Expand
2

Mammary Stromal-Epithelial Organoid Co-Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS-purified GFP+ cells from the lin- stromal fraction of PdgfrαCreR26mTmG mammary tissue were co-cultured with sorted tdTomato+ epithelial cells from Cre-R26mTmG mammary glands on top of a thin layer of phenol red-free matrigel (BD Biosciences) in a Lab-Tek II 4 chambered cover glass system (Nunc) in DMEM:F12 medium containing 5% FBS (GIBCO), insulin (Life Technologies), EGF (STEMCELL Technologies), bFGF (STEMCELL Technologies), hydrocortisone (STEMCELL Technologies), Rock inhibitor (Reagents Direct) in 5% oxygen conditions. After 4 days of organoid growth, cultures were treated with vehicle control (4 mM HCl + 0.1% BSA) or 100 ng/ml PDGFCC (R&D systems) and imaged overnight with Zen software using 20 × /0.8 Plan-Apochromat objective lens of an inverted motorized Zeiss AxioObserver microscope equipped with a stage top heated CO2 incubator.
+ Open protocol
+ Expand
3

Quantifying PDGFCC-induced Stromal Cell Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
In a modified Boyden Chamber assay, PdgfrαCreR26mTmG GFP+ stromal cells (40,000 cells/well) suspended in DMEM:F12 medium were placed on 6.5 mm transwell inserts with a 8.0 μm pore size and underside coated with 30μl of phenol red-free matrigel (BD Biociences) in 24 well plates (Corning). DMEM: F12 medium with vehicle control (4 mM HCl + 0.1% BSA) or 100 ng/ml PDGFCC (R&D systems) was added to the bottom chambers and cells incubated at 37 C for 4 h. Non-migrated cells were removed from the insert with a cotton swab, and migrated cells in the matrigel layer were fixed with paraformaldehyde and washed with PBS. GFP+ migrated cells were counted after imaging inserts on a cell imaging dish (Eppendorf) using a Zeiss LSM700 confocal microscope with Fluar 10X/0.50NA objective lens. Four microscope fields were counted per well and treatments performed in triplicate.
+ Open protocol
+ Expand
4

Chemotactic migration of cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used recombinant human bone morphogenetic protein-2 (BMP-2; Medtronic, Minneapolis, MN, USA), hepatocyte growth factor (HGF; Peprotech, Rocky Hill, NJ, USA), insulin-like growth factor-1 (IGF-1; Peprotech), platelet-derived growth factor-AA (PDGF-AA; R&D Systems), PDGF-AB (R&D Systems), PDGF-BB (R&D Systems), PDGF-CC (R&D Systems), PDGF-DD (R&D Systems), stromal cell-derived factor-1α (SDF-1α; R&D Systems), transforming growth factor-β3 (TGF-β3; Miltenyi Biotec, Bergisch Gladbach, Germany). The medium containing 0.5% FBS in the lower chamber was supplemented with 100 ng/mL BMP-2, 100 ng/mL HGF, 100 ng/mL IGF-1, 10 ng/mL PDGF-BB, 100 ng/mL SDF-1α, or 10 ng/mL TGF-β3. After 48 h incubation, migrated cells were counted. The PDGF isoforms were compared by adding PDGF-AA, AB, BB, CC, or DD to the lower chamber at 100 ng/mL. Crenolanib (Selleck Chemicals, Houston, TX, USA), an inhibitor of PDGF receptor (PDGFR) α and β, was added to both the upper and lower chambers during the migration assay.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!